http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MY-125808-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D253-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D253-075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D253-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate | 1999-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e50d776a73f979c2f70a0788636aa96 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f68681447fdc0351cacb9f4783bdbe72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ed062160e991cef37d119d7107096cf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef152cc1a628f65ec3c05e36c70f8811 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7dd6a1b8ced7b6f7de23d0a84887f61 |
| publicationDate | 2006-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MY-125808-A |
| titleOfInvention | Il-5 inhibiting 6-azauracil derivatives |
| abstract | THE PRESENT INVENTION IS CONCERNED WITH THE COMPOUNDS OF FORMULA(FORMULA I)A N-OXIDE, A PHARN1ACEUTICALLY ACCEPTABLE ADDITION SALT, A QUATERNARY AMINE OR A STEREOCHEMICALLY ISOMERIC FONTL THEREOF, WHEREIN P IS 0 TO 4; Q IS 0 TO 5; X IS 0, S, NR3 OR A DIRECT BOND; OR -X-R2 IS CN; R 1 IS H, OR, HALO, NH2, MONO- OR DI(CL-4ALKYL)NH2, CL-6ALKYL, CL-6ALKYI0, C3-7CYCLOALKYL, ARYL, ARYICL-6ALKYL, NH2CI-4ALKYL, MONO- OR 2 DI(CL-4ALKYL)NH2CI-4ALKYL OR MONO- OR DI(CL-4ALKYL)NH2CI-4ALKYINH2; R IS ARYL, HETL, OPTIONALLY SUBSTITUTED C3- 7CYCLOALKYL, OPTIONALLY SUBSTITUTED CL-6ALKYL; R3 IS H OR 4 5 CL-4ALKYL; RAND R ARE -C(=O)-Z-R 14, CL-6ALKYL, HALO, POLYHALOCL-6ALKYL, OR,MERCAPTO, CL-6ALKYI0, CL-6ALKYLTHIO, CL-6ALKYIC(=0)O, ARYL, CYANO, NITRO, HET3, R6, NR7R8 OR CI-4AJKYL SUBSTITUTED WITH -C(=O)-Z-R 14, HET3, R6 OR NR 7R8; Z IS 0, S, NH, -CH2-O- OR -CH2-S-; R 14 IS H, CI-2OACYL, OPTIONALLY SUBSTITUTED CI-2OALKYL, OPTIONALLY SUBSTITUTED C3-2OALKENYL, C3-2OALKYNYL, C3-7CYCLOALKYL, POLYHALOCI-2OALKYL, HET5, PHENYJ; OR R 14 IS AN OXYGEN CONTAINING RADICAL; ARYL IS OPTIONALLY SUBSTITUTED PHENYL; HETL, HET2, HET3 AND HET5 ARE OPTIONALLY SUBSTITUTED HETEROCYCLES; HET4 IS A MONOCYCLIC HETEROCYCLE; 2 PROVIDED HOWEVER THAT R IS OTHER THAN NH2C(=0), CI-6ALKYIOC(=O)CI-6ALKYL; AND R II IS OTHER THAN COOH, CI-4AJKYIOC(=O), NH2C(=0), CI-4ALKYINH2C(=O), OHCI-4AJKYINH2C(=0), CI-4ALKYIC(=O)NH2C(=O), C3-7CYCLOALKYLNH2C(=0); AND R 7, R8, R9, RIO, R 12, R 13, R IS AND R 16 ARE OTHER THAN CI-4ALKYIC(=O)OCI-4ALKYIC(=O), OHCI-4ALKYLC(=0); AND HET3 IS OTHER THAN A MONOCYCLIC HETEROCYCLE SUSBSTITUTED WITH COOH OR CL-4ALKYIOC(=0); AND THE COMPOUNDS OF FONTLULA (1) CONTAIN AT LEAST ONE -C(=O)-Z-R 14 MOIETY; TO PROCESSES FOR THEIR PREPARATION AND COMPOSITIONS COMPRISING THEM. IT FURTHER RELATES TO THEIR USE AS A MEDICINE. |
| priorityDate | 1998-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 38.